{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2432, 
        2446
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4254, 
        4277
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2353, 
        2380
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2332, 
        2350
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        528, 
        557
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4177, 
        4212
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2259, 
        2285
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2448, 
        2455
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2468, 
        2469
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2290, 
        2298
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2306, 
        2322
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2422, 
        2431
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2287, 
        2288
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2299, 
        2300
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2382, 
        2383
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2670, 
        2671
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2747, 
        2764
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D0306984^CLIA|eMARCPlus|TN Cancer Registry|20170915000110||ORU^R01^ORU_R01|201709150001100001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-SR-002740^PathSys^44D0306984^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170831000000|||||||20170901000000|&Prostate, Radical Resection, Lymph Node, Biopsy, PQRS Radical Prostatectomy|1194841452^^^^^^MD^^CMS^D^^^NPI||||||20170905000000|||F||||||C61^Malignant neoplasm of prostate^I10|1487897187&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received in formalin labeled \", prostate\" is a 35 g prostatectomy specimen. The prostate measures 4.1 cm transversely, 3.3 cm from anterior to posterior, and 4.0 cm from superior to inferior. The capsule is tan to tan-pink and diffusely shaggy. The right seminal vesicle measures 3.5 cm in length x 1.0 cm in diameter, and the right vas deferens measures 1.5 cm in length x 0.6 cm in diameter. The left vas deferens measures 0.5 cm in length x 0.7 cm in diameter, and the left seminal vesicle is received separately in the container and measures 2.8 cm in length x 1.0 cm in diameter. The right half of the specimen is inked in blue, and the left half is inked in orange. Serial sectioning reveals tan to tan-pink glistening cut surfaces with a mild amount of periurethral nodularity. A 1.6 cm in greatest dimension tan-white ill-defined possible lesion is identified in the left posterior lobe. Representative sections are submitted as follows: 1A. right seminal vesicle and vas deferens 2/1, 1B. left seminal vesicle and vas deferens 2/1, 1C. right apical margin 3/1, 1D. left apical margin 4/1, 1E-1K. right side of prostate proceeding from apex to base 11/ each, 1L-1R. left side of prostate proceeding from apex to base 1/1 each, 1S. right base margin 5/1, 1T. left base margin 4/1. 2. Received in formalin labeled \", preprostatic tissue, right and left pelvic lymph node\" is a 7.0 x 5.0 x 1.5 cm aggregate of delicate and lobulated adipose tissue. Sectioning reveals 2 possible lymph nodes measuring 3.5 and 4.8 cm in greatest dimension. Representative sections to include both possible nodes are submitted as follows: 2A-2B. 1 section node 2/1 each, 2C-2E. 1 section node 2/1 each. (AC2)\n\n\nPath report.site of origin\n\n1. Prostate 2. Pre-prostatic tissue, R and L pelvic lymph nodes\n\n\nPath report.final diagnosis\n\n1. Prostate, robotic prostatectomy:     Prostatic adenocarcinoma, Gleason pattern 4+5=9.     Tumor involves the right and left apex to base.     No extraprostatic extension is identified.     Margins are negative for tumor.     Seminal vesicles and vas deferentia are negative for tumor. 2. Lymph nodes, right and left pelvic, excision:     Two benign lymph nodes. CANCER CHECKLIST: PROSTATE GLAND: Radical Prostatectomy 3.000.001.1000043 SPECIMEN  Procedure: Radical prostatectomy Prostate Size  Prostate Weight (g): 35 grams  Prostate Size in Centimeters (cm): 4.1 x 4.0 x 3.3 cm TUMOR  Histologic Type: Acinar adenocarcinoma Histologic Grade  Gleason Pattern: Gleason pattern  Primary Gleason Pattern: Pattern 4  Secondary Gleason Pattern: Pattern 5  Tertiary Gleason Pattern#: Pattern 3  Total Gleason Score: 9  Grade Group: Grade group 5  Intraductal Carcinoma (IDC): Not identified Tumor Extent  Tumor Quantitation: Estimated percentage of prostate involved by tumor (specify %), Tumor size (dominant nodule, if present)  Estimated percentage of prostate involved by tumor (specify %): 20%  Greatest Dimension in Millimeters (mm): 16mm  Extraprostatic Extension (EPE): Not identified  Urinary Bladder Neck Invasion: Not identified  Seminal Vesicle Invasion: Not identified Accessory Findings  Treatment Effect: No known presurgical therapy  Lymphovascular Invasion: Not Identified  Perineural Invasion: Present MARGINS  Margins: Uninvolved by invasive carcinoma LYMPH NODES  Number of Lymph Nodes Involved: None identified  Extranodal Extension: Not identified  Number of Lymph Nodes Examined: Specify number  Specify number: 2 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  Primary Tumor (pT)#: pT2: Organ confined  Regional Lymph Nodes (pN): pN0: No positive regional nodes\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Prostate carcinoma\n\n\n"
}